Literature DB >> 9601944

The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells.

K L Arnett1, W Huang, N M Valiante, L D Barber, P Parham.   

Abstract

HLA-B*0801 is unique among HLA-B allotypes in having dominant amino acid anchors at positions 3 and 5 of the peptide-binding motif. HLA-B*0802 is a variant of HLA-B*0801 in which the Bw6 sequence motif is replaced by a Bw4 sequence motif. This change, involving substitutions at positions 77, 80, 81, 82, and 83 of the B*08 heavy chain, is probably the result of a single evolutionary event of interallelic conversion. Moreover, the difference between B*0802 and B*0801 is sufficient to stimulate a cytotoxic T-cell response. To assess further the functional impact of the Bw4 motif on a B8 background, we compared the peptide-binding specificity of the B*0801 and B*0802 allotypes by sequencing the mixture of peptides endogenously bound to B*0802 and 12 individual peptides purified from that mixture. The HLA-B*0802 allotype, while able to bind some peptides bound by B*0801, has a broader repertoire of endogenously bound peptides than B*0801: the peptides bound by B*0802 are more variable in length and exhibit greater diversity in the carboxyl-terminal amino acid which interacts with the F pocket.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601944     DOI: 10.1007/s002510050400

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  5 in total

1.  The nature of peptides presented by an HLA class I low expression allele.

Authors:  Jan Hinrichs; Daniel Föll; Christina Bade-Döding; Trevor Huyton; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

2.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

Authors:  P O Flores-Villanueva; E J Yunis; J C Delgado; E Vittinghoff; S Buchbinder; J Y Leung; A M Uglialoro; O P Clavijo; E S Rosenberg; S A Kalams; J D Braun; S L Boswell; B D Walker; A E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

3.  Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants.

Authors:  Christina Bade-Doeding; David S DeLuca; Axel Seltsam; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Immunogenetics       Date:  2007-02-10       Impact factor: 2.846

4.  High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells.

Authors:  Saulius Jarmalavicius; Yvonne Welte; Peter Walden
Journal:  J Biol Chem       Date:  2012-08-06       Impact factor: 5.157

5.  The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.

Authors:  Philippa M Saunders; Julian P Vivian; Nikola Baschuk; Travis Beddoe; Jacqueline Widjaja; Geraldine M O'Connor; Corinne Hitchen; Phillip Pymm; Daniel M Andrews; Stephanie Gras; Daniel W McVicar; Jamie Rossjohn; Andrew G Brooks
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.